• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

工程化大分子的粗粒分子动力学研究用于抑制巨噬细胞清道夫受体摄取氧化型低密度脂蛋白。

Coarse grained molecular dynamics of engineered macromolecules for the inhibition of oxidized low-density lipoprotein uptake by macrophage scavenger receptors.

机构信息

Department of Biomedical Engineering, Rutgers University, Piscataway, New Jersey 08854, United States.

出版信息

Biomacromolecules. 2013 Aug 12;14(8):2499-509. doi: 10.1021/bm301764x. Epub 2013 Jul 3.

DOI:10.1021/bm301764x
PMID:23738575
Abstract

Atherosclerosis is a condition resulting from the accumulation of oxidized low-density lipoproteins (oxLDLs) in arterial walls. Previously developed macromolecules consisting of alkyl chains and polyethylene glycol (PEG) on a mucic acid backbone, termed nanolipoblockers (NLBs) are hypothesized to mitigate the uptake of oxLDL by macrophage scavenger receptors. In this work, we developed a coarse grained model to characterize the interactions between NLBs with a segment of human scavenger receptor A (SR-A), a key receptor domain that regulates cholesterol uptake and foam cell conversion of macrophages, and studied NLB ability to block oxLDL uptake in PBMC macrophages. We focused on four different NLB configurations with variable molecular charge, charge location, and degree of NLB micellization. Kinetic studies showed that three of the four NLBs form micelles within 300 ns and of sizes comparable to literature results. In the presence of SR-A, micelle-forming NLBs interacted with the receptor primarily in an aggregated state rather than as single unimers. The model showed that incorporation of an anionic charge near the NLB mucic acid head resulted in enhanced interaction with the proposed binding pocket of SR-A compared to uncharged NLBs. By contrast, NLBs with an anionic charge located at the PEG tail showed no interaction increase as NLB aggregates were predominately observed to interact away from the oxLDL binding site. Additionally, using two different methods to assess the number of contacts that each NLB type formed with SR-A, we found that the rank order of contacts coincided with our experimental flow cytometry results evaluating the ability of the different NLBs to block the uptake of oxLDL.

摘要

动脉粥样硬化是一种由于动脉壁中氧化的低密度脂蛋白(oxLDL)积累而导致的疾病。先前开发的由烷基链和聚乙二醇(PEG)组成的大分子,以粘酸为骨架,称为纳米脂质阻断剂(NLB),据推测可以减轻巨噬细胞清道夫受体对 oxLDL 的摄取。在这项工作中,我们开发了一个粗粒度模型来描述 NLB 与人类清道夫受体 A(SR-A)的一段的相互作用,SR-A 是调节胆固醇摄取和巨噬细胞泡沫细胞转化的关键受体结构域,并研究了 NLB 阻断 PBMC 巨噬细胞中 oxLDL 摄取的能力。我们专注于四种不同的 NLB 构型,它们具有可变的分子电荷、电荷位置和 NLB 胶束化程度。动力学研究表明,四种 NLB 中的三种在 300ns 内形成胶束,大小与文献结果相当。在 SR-A 存在的情况下,形成胶束的 NLB 与受体主要以聚集状态相互作用,而不是以单个单体形式相互作用。该模型表明,在 NLB 粘酸头部附近引入阴离子电荷会增强与 SR-A 的拟结合口袋的相互作用,而与不带电的 NLB 相比。相比之下,带负电荷的 NLB 位于 PEG 尾部,由于 NLB 聚集体主要观察到与 oxLDL 结合位点相互作用,因此没有观察到相互作用的增加。此外,使用两种不同的方法来评估每种 NLB 类型与 SR-A 形成的接触数量,我们发现接触数量的排序与我们评估不同 NLB 阻断 oxLDL 摄取能力的实验流式细胞术结果一致。

相似文献

1
Coarse grained molecular dynamics of engineered macromolecules for the inhibition of oxidized low-density lipoprotein uptake by macrophage scavenger receptors.工程化大分子的粗粒分子动力学研究用于抑制巨噬细胞清道夫受体摄取氧化型低密度脂蛋白。
Biomacromolecules. 2013 Aug 12;14(8):2499-509. doi: 10.1021/bm301764x. Epub 2013 Jul 3.
2
Structure-activity relations of nanolipoblockers with the atherogenic domain of human macrophage scavenger receptor A.纳米脂质阻滞剂与人类巨噬细胞清道夫受体A致动脉粥样化结构域的构效关系
Biomacromolecules. 2009 Jun 8;10(6):1381-91. doi: 10.1021/bm8014522.
3
Nanoscale amphiphilic macromolecules with variable lipophilicity and stereochemistry modulate inhibition of oxidized low-density lipoprotein uptake.具有可变疏水性和立体化学的纳米级两亲性大分子调节氧化型低密度脂蛋白摄取的抑制作用。
Biomacromolecules. 2013 Aug 12;14(8):2463-9. doi: 10.1021/bm400537w. Epub 2013 Jul 8.
4
Dual use of amphiphilic macromolecules as cholesterol efflux triggers and inhibitors of macrophage athero-inflammation.两亲性大分子作为胆固醇流出触发因子和巨噬细胞动脉粥样炎症抑制剂的双重用途。
Biomaterials. 2011 Nov;32(32):8319-27. doi: 10.1016/j.biomaterials.2011.07.039. Epub 2011 Aug 3.
5
High affinity saturable uptake of oxidized low density lipoprotein by macrophages from mice lacking the scavenger receptor class A type I/II.缺乏I/II型A类清道夫受体的小鼠巨噬细胞对氧化型低密度脂蛋白的高亲和力饱和摄取。
J Biol Chem. 1997 May 16;272(20):12938-44. doi: 10.1074/jbc.272.20.12938.
6
Engineered polymeric nanoparticles for receptor-targeted blockage of oxidized low density lipoprotein uptake and atherogenesis in macrophages.工程化聚合物纳米颗粒用于受体靶向阻断巨噬细胞中氧化低密度脂蛋白的摄取及动脉粥样硬化的发生。
Biomacromolecules. 2006 Jun;7(6):1796-805. doi: 10.1021/bm0600872.
7
Endophilin-A2-mediated increase in scavenger receptor expression contributes to macrophage-derived foam cell formation.内吞蛋白-A2介导的清道夫受体表达增加促进巨噬细胞源性泡沫细胞的形成。
Atherosclerosis. 2016 Nov;254:133-141. doi: 10.1016/j.atherosclerosis.2016.10.009. Epub 2016 Oct 6.
8
CD14 is a key mediator of both lysophosphatidic acid and lipopolysaccharide induction of foam cell formation.CD14是溶血磷脂酸和脂多糖诱导泡沫细胞形成的关键介质。
J Biol Chem. 2017 Sep 1;292(35):14391-14400. doi: 10.1074/jbc.M117.781807. Epub 2017 Jul 13.
9
Controllable inhibition of cellular uptake of oxidized low-density lipoprotein: structure-function relationships for nanoscale amphiphilic polymers.可控制的氧化型低密度脂蛋白细胞摄取抑制:纳米两亲聚合物的结构-功能关系。
Acta Biomater. 2010 Aug;6(8):3081-91. doi: 10.1016/j.actbio.2010.02.019. Epub 2010 Feb 17.
10
Oxidized low density lipoprotein decreases macrophage expression of scavenger receptor B-I.氧化型低密度脂蛋白降低巨噬细胞清道夫受体B-I的表达。
J Biol Chem. 2001 May 11;276(19):16567-72. doi: 10.1074/jbc.M011302200. Epub 2001 Feb 6.

引用本文的文献

1
Multiscale technologies for treatment of ischemic cardiomyopathy.多尺度技术治疗缺血性心肌病。
Nat Nanotechnol. 2017 Sep 6;12(9):845-855. doi: 10.1038/nnano.2017.167.
2
Nanotherapeutics for inhibition of atherogenesis and modulation of inflammation in atherosclerotic plaques.用于抑制动脉粥样硬化形成和调节动脉粥样硬化斑块炎症的纳米疗法。
Cardiovasc Res. 2016 Feb 1;109(2):283-93. doi: 10.1093/cvr/cvv237. Epub 2015 Oct 14.
3
Sugar-based amphiphilic nanoparticles arrest atherosclerosis in vivo.基于糖的两亲性纳米颗粒在体内抑制动脉粥样硬化。
Proc Natl Acad Sci U S A. 2015 Mar 3;112(9):2693-8. doi: 10.1073/pnas.1424594112. Epub 2015 Feb 17.
4
Biodegradable Janus nanoparticles for local pulmonary delivery of hydrophilic and hydrophobic molecules to the lungs.用于将亲水性和疏水性分子局部递送至肺部的可生物降解Janus纳米颗粒。
Langmuir. 2014 Nov 4;30(43):12941-9. doi: 10.1021/la502144z. Epub 2014 Oct 27.